| Updates in Primary ACL Reconstruction |
|
Headline : None
Date : Tuesday, 23 January 2024
Start Time : 00:00
End Time : 00:00
Location : Persian Gulf Hall
|
|
Presentations |
|
|
|
00:00 - 00:00
|
ALL and lateral tenodesis in ACL reconstruction: Why? When? and How?
Philippe Landreau |
|
|
|
|
|
|
|
|
|
|
|
00:00 - 00:00 | Panel : Panel Discussion and Case Presentation
Panel Members : Speakers , Hoseinali Hadi , Sohrab Keyhani , Ali Shahsavaripour , Babak Haghpanah Amir Mohammad Navali , Amin Moradi |
| PCL |
|
Headline : None
Date : Tuesday, 23 January 2024
Start Time : 00:00
End Time : 00:00
Location : Avicenna Hall
|
|
Presentations |
|
00:00 - 00:00
|
What does PCL anatomy actually look like? New anatomical approach to reconstruction
Robert Smigielski |
|
00:00 - 00:00
|
Isolated PCL injury, when do you approach? Surgical Tips and Tricks
Gholamreza Ghorbani Amjad |
|
|
|
|
|
|
|
00:00 - 00:00
|
Q & A
|
|
00:00 - 00:00 | Panel : Panel Discussion
Panel Members : Speakers , Mehdi Moayedfar , Farzad Amouzadeh |
| Spine Hip Knee Syndrome |
|
Headline : None
Date : Tuesday, 23 January 2024
Start Time : 00:00
End Time : 00:00
Location : Avicenna Hall
|
|
Presentations |
|
|
|
|
|
00:00 - 00:00
|
Case presentation & Discussion
|
|
00:00 - 00:00
|
Management dilemma when hip osteoarthritis coexists With Spine Degeneration
Francesco Traina |
|
00:00 - 00:00
|
Severe concomitant spine and knee deformity, which one should be addressed first
Farshad Nikouei |
|
00:00 - 00:00
|
Q & A
|
|
00:00 - 00:00 | Panel : Panel Discussion
Panel Members : Speakers , Keyvan Ahadi , Kaveh Gharanizadeh , Babak Mirzashahi |
| Updates on FAI Syndrome |
|
Headline : None
Date : Tuesday, 23 January 2024
Start Time : 00:00
End Time : 00:00
Location : Avicenna Hall
|
|
Presentations |
|
00:00 - 00:00
|
Introduction
|
|
|
|
|
|
00:00 - 00:00
|
Q & A
|
|
|
|
|
|
00:00 - 00:00 | Panel : Panel Discussion and Case Presentation
Panel Members : Speakers , Morteza Kalhor , Mansour Abolghasemian , Kaveh Gharanizadeh , Ibrahim Tuneay |
|
00:00 - 00:00
|
Q & A
|